Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-23

FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for Zyprexa Intramuscular (olanzapine) from Eli Lilly, adding the intramuscular formulation to the product's approval. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYPREXA INTRAMUSCULAR (olanzapine)

Snippet

SUPPL AP for ZYPREXA INTRAMUSCULAR (OLANZAPINE)